Theratechnologies Inc. - Common Shares (THTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common Shares
Symbol
THTX
Shares outstanding
45,951,901
Price per share
$3.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,743,561
Total reported value
$5,895,962
% of total 13F portfolios
0%
Share change
-10,093,668
Value change
-$22,240,756
Number of holders
10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Theratechnologies Inc. - Common Shares (THTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 10% $13,779,946 4,801,375 SOLEUS CAPITAL MASTER FUND, L.P. 11 Apr 2025
SUMMER ROAD LLC 5.8% $8,721,671 2,683,591 Summer Road LLC 22 Sep 2025
HIRSCHMAN ORIN 3.4% -45% $4,914,679 -$2,228,024 2,082,491 -31% Orin Hirschman 30 Jun 2025
MORGAN STANLEY 1.9% $2,704,634 858,614 Morgan Stanley 30 Jun 2025

As of 30 Sep 2025, 10 institutional investors reported holding 1,743,561 shares of Theratechnologies Inc. - Common Shares (THTX). This represents 3.8% of the company’s total 45,951,901 outstanding shares.

Institutional Holders of Theratechnologies Inc. - Common Shares (THTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$156,276 $3.21 0
2025 Q3 1,743,561 $5,895,962 -$22,240,756 $3.22 10
2025 Q2 11,936,760 $28,160,527 -$1,916,687 $2.36 49
2025 Q1 12,768,275 $17,969,120 -$1,693,587 $1.40 38
2024 Q4 13,917,479 $25,195,742 -$1,136,193 $1.81 41
2024 Q3 14,553,801 $18,035,917 +$198,481 $1.24 36
2024 Q2 14,389,276 $20,162,125 +$190,593 $1.40 33
2024 Q1 14,031,116 $23,257,967 -$1,579,687 $1.66 29
2023 Q4 15,201,814 $24,635,050 +$14,327,233 $1.62 29
2023 Q3 6,344,446 $13,639,991 +$13,639,991 $2.15 27